These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6862731)

  • 1. Therapy for intercurrent respiratory infections in COLD patients: report on 200 patients.
    Turco P; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Dal Negro RW
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):260-2. PubMed ID: 6862731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic and prophylactic effects of cephalexin and bromhexine in respiratory tract complications of abdominal surgery.
    Palmieri B; Monni S; Misella A; Cogni P
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):143-6. PubMed ID: 6853000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ciprofloxacin by the intravenous route in the treatment of respiratory infections].
    Mangiarotti P; Manara G; Bianchi L; Piccioni PD; Grassi C
    G Ital Chemioter; 1989; 36(1-3):89-94. PubMed ID: 2488917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and exacerbated chronic respiratory tract infections: treatment with a combination of cefuroxime and acetylcysteine.
    Dal Negro RW; Turco P; Zoccatelli O; Pomari C; Trevisan F
    Int J Clin Pharmacol Res; 1985; 5(5):345-50. PubMed ID: 4066085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
    Silvia G; Giambrone F; Battaglia E; Romano M
    G Clin Med; 1981 Mar; 62(3):209-27. PubMed ID: 7250579
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined cefuroxime plus acetylcysteine in the treatment of bacterial infections of the respiratory tract.
    Bonavita E
    Drugs Exp Clin Res; 1985; 11(6):361-8. PubMed ID: 3836134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection. A randomized controlled trial.
    Roa CC; Dantes RB
    Arzneimittelforschung; 1995 Mar; 45(3):267-72. PubMed ID: 7741782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of twice daily cephalexin.
    Browning AK
    Pharmatherapeutica; 1981; 2(9):559-64. PubMed ID: 7267673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial in patients with infectious diseases of a new injectable cephalosporin derivative: lysine salt of cephalexin].
    Restivo O; Caruso R
    Arch Maragliano Patol Clin; 1976; 32():37-45. PubMed ID: 1053292
    [No Abstract]   [Full Text] [Related]  

  • 10. [Causative role of infections with viruses or atypical pathogens in acute exacerbations of chronic bronchitis less frequent than expected].
    Roessingh PH; van Loon AM; Lammers JW; Hoepelman IM
    Ned Tijdschr Geneeskd; 1996 Nov; 140(48):2406-10. PubMed ID: 8984413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of cefadroxil in acute and chronic bacterial infections of the respiratory tract].
    Nosenzo M; Razzetti A; Delle Piane M; Faravelli B; Suffritti G
    Clin Ter; 1983 Mar; 104(5):383-9. PubMed ID: 6342913
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Paxirasol aerosol on the clinical condition and objective functional respiratory parameters of obstructive respiratory tract disease patients.
    Mészáros L; Molnár B; Beke M
    Ther Hung; 1991; 39(3):128-32. PubMed ID: 1818426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
    Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
    Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicenter research on the clinical effectiveness and tolerability of an antibacterial drug. Results of 1063 cases].
    Privitera G; Bonino S; Del Mastro S
    Clin Ter; 1982 Apr; 101(2):123-36. PubMed ID: 7094544
    [No Abstract]   [Full Text] [Related]  

  • 15. [New therapeutic possibilities of amminosidin in pneumology (bacteriologic, physiopathologic and clinical observations)].
    Mariani B; Velluti G; Marchioni CF
    Atti Accad Med Lomb; 1973; 28(1-4):75-93. PubMed ID: 4807503
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of respiratory tract infections with augmentin.
    Cioffi R; Turco D; Alfano B; Di Salvatore F; Gnasso P; Mastroianni S
    J Chemother; 1989 Jul; 1(4 Suppl):766-7. PubMed ID: 16312630
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe exacerbations of COPD patients: the role of pulmonary infections.
    Fagon JY; Chastre J
    Semin Respir Infect; 1996 Jun; 11(2):109-18. PubMed ID: 8776780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic trial in a children's hospital of a new orally administered form of cephalexin].
    Betend B; Goddon R; David L
    Lyon Med; 1972 Sep; 228(14):205-8. PubMed ID: 5082769
    [No Abstract]   [Full Text] [Related]  

  • 20. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.